Cargando…

Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma

Therapeutic drug concentrations measured in plasma are of limited value as reference intervals for interpretation in post-mortem (PM) toxicology. In this study, drug concentration distributions were studied in PM femoral venous blood from 57 903 Finnish autopsy cases representing all causes of death...

Descripción completa

Detalles Bibliográficos
Autores principales: Launiainen, Terhi, Ojanperä, Ilkka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237191/
https://www.ncbi.nlm.nih.gov/pubmed/23881890
http://dx.doi.org/10.1002/dta.1507
_version_ 1782345308098789376
author Launiainen, Terhi
Ojanperä, Ilkka
author_facet Launiainen, Terhi
Ojanperä, Ilkka
author_sort Launiainen, Terhi
collection PubMed
description Therapeutic drug concentrations measured in plasma are of limited value as reference intervals for interpretation in post-mortem (PM) toxicology. In this study, drug concentration distributions were studied in PM femoral venous blood from 57 903 Finnish autopsy cases representing all causes of death during an 11-year period. Cause-of-death information was obtained from death certificates issued by forensic pathologists. Median, mean, and upper percentile (90th, 95th, 97.5th) concentrations were calculated for 129 drugs. To illustrate how PM median concentrations relate to established therapeutic ranges in plasma, a PM blood/plasma relationship was calculated for each drug. Males represented 75% of the subjects and showed a lower median age (55 yrs) than females (59 yrs). In 43% of these cases, blood alcohol concentration was higher than 0.2‰, and the median was 1.8‰. Sixty-one (47%) of the 129 drugs showed a PM blood/plasma relationship of 1. For 22 drugs (17%), the relationship was <1, and for 46 drugs (35%), the relationship was >1. No marked correlation was found between the PM blood/plasma relationship and the volume of distribution (V(d)). For 36 drugs, more than 10% of cases were fatal poisonings attributed to this drug as the main finding. These drug concentration distributions based on a large database provide a helpful reference not only to forensic toxicologists and pathologists but also to clinical pharmacologists in charge of interpreting drug concentrations in PM cases. © 2013 The Authors. Drug Testing and Analysis published by John Wiley & Sons, Ltd.
format Online
Article
Text
id pubmed-4237191
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-42371912014-12-15 Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma Launiainen, Terhi Ojanperä, Ilkka Drug Test Anal Research Articles Therapeutic drug concentrations measured in plasma are of limited value as reference intervals for interpretation in post-mortem (PM) toxicology. In this study, drug concentration distributions were studied in PM femoral venous blood from 57 903 Finnish autopsy cases representing all causes of death during an 11-year period. Cause-of-death information was obtained from death certificates issued by forensic pathologists. Median, mean, and upper percentile (90th, 95th, 97.5th) concentrations were calculated for 129 drugs. To illustrate how PM median concentrations relate to established therapeutic ranges in plasma, a PM blood/plasma relationship was calculated for each drug. Males represented 75% of the subjects and showed a lower median age (55 yrs) than females (59 yrs). In 43% of these cases, blood alcohol concentration was higher than 0.2‰, and the median was 1.8‰. Sixty-one (47%) of the 129 drugs showed a PM blood/plasma relationship of 1. For 22 drugs (17%), the relationship was <1, and for 46 drugs (35%), the relationship was >1. No marked correlation was found between the PM blood/plasma relationship and the volume of distribution (V(d)). For 36 drugs, more than 10% of cases were fatal poisonings attributed to this drug as the main finding. These drug concentration distributions based on a large database provide a helpful reference not only to forensic toxicologists and pathologists but also to clinical pharmacologists in charge of interpreting drug concentrations in PM cases. © 2013 The Authors. Drug Testing and Analysis published by John Wiley & Sons, Ltd. BlackWell Publishing Ltd 2014-04 2013-07-23 /pmc/articles/PMC4237191/ /pubmed/23881890 http://dx.doi.org/10.1002/dta.1507 Text en © 2013 The Authors. Drug Testing and Analysis published by John Wiley & Sons, Ltd. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Launiainen, Terhi
Ojanperä, Ilkka
Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma
title Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma
title_full Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma
title_fullStr Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma
title_full_unstemmed Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma
title_short Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma
title_sort drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237191/
https://www.ncbi.nlm.nih.gov/pubmed/23881890
http://dx.doi.org/10.1002/dta.1507
work_keys_str_mv AT launiainenterhi drugconcentrationsinpostmortemfemoralbloodcomparedwiththerapeuticconcentrationsinplasma
AT ojanperailkka drugconcentrationsinpostmortemfemoralbloodcomparedwiththerapeuticconcentrationsinplasma